Mitchell P. Kopin 13D/13G Filings for Virpax Pharmaceuticals, Inc. (VRPX)

Mitchell P. Kopin 13D and 13G filings for Virpax Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-05-23
4:06 pm
Purchase
2024-05-1413GVirpax Pharmaceuticals, Inc.
VRPX
Mitchell P. Kopin4,429
4.990%
4,429increase
(New Position)
Filing